American College of Obstetricians and Gynecologists
Connections
Newsday's coverage
-
New studies clarify mammogram guidelines
50-75 should be screened every two years, the task force said.By contrast, the American Cancer Society and American College of Obstetricians and Gynecologists recommend mammogram screening every year beginning at age 40. Two studies published this week by Read more »
Around the web
-
Viewpoints: Legislation helps state lead in the battle for women's rights
All across America, elected officials at the state and national levels are moving to restrict access to reproductive health care and reproductive rights. Whether it's defunding family planning services in Texas and Arizona or restricting reproductive rig from Sacramento Bee Read more »
-
Many pregnant women may not get STD tests
NEW YORK (Reuters Health) - Despite recommendations that pregnant women have tests for certain sexually transmitted diseases, many may not be getting them, a new study suggests. Researchers found that of nearly 1.3 million U.S. women who had blood work d from Reuters.co.uk Read more »
-
Small, disposable vaginal speculum introduced at ACOG Annual Clinical Meeting
Welch Allyn, a leading global provider of medical diagnostic solutions, today introduced the industry's first extra small, disposable vaginal speculum at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting in San Diego. from News-Medical.net Read more »
-
Studies seek to clarify guidelines on mammograms
MELVILLE, N.Y. • Two new studies have tried to make it easier to determine whether women in their 40s should get routine mammograms, an issue that remains fraught with controversy. In 2009, the U.S. Preventive Services Task Force, an independent governme from St. Louis Post-Dispatch Read more »
-
New Studies on Agile Therapeutics' Low-Dose Contraceptive Patch to Be Presented at the American College of Obstetricians and Gynecologists' Annual Clinical Meeting
PRINCETON, NJ--(Marketwire - Apr 25, 2012) - Agile Therapeutics, a pharmaceutical company focused on developing and commercializing more convenient women's contraceptive products, announced today that three new studies, including Phase III data, using AG from MarketWire Read more »
